Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Assessing Patient and Provider Perspectives, Clinical Practice, Behaviors, and Knowledge on Hemophilia A Care

Tariqa A Ackbarali, PhDc), Stacy E. Croteau, MD, Steven W. Pipe, MD, Kelly Tickle, MSN, APN, CWON, PCNS-BS, PPCNP-BC, Lori Long, Sonji Wilkes, BS, Kate Nammacher, MPH, Neil Frick, Katie Kowalski, Wendy Turell

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141657

Published: 2020

Journal Articles

First-in-Human Phase 1/2 Clinical Trial of SIG-001, an Innovative Shielded Cell Therapy Platform, for Hemophilia Α

Amy D Shapiro, MD, Barbara A. Konkle, MD, Stacy E. Croteau, MD, Wolfgang A. Miesbach, MD, Charles Richard Morris Hay, MDFRCP,FRCPath, Rashid Kazmi, MBBS, Marina Mihova, Savita Rangarajan, MD MBBS, John Pasi, MB, ChB, PhD FRCP, FRCPath, FRCPCH

Blood (2020) 136 (Supplement 1): 8.

https://doi.org/10.1182/blood-2020-141381

Published: 2020

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020

Journal Articles

Incidence of Pulmonary Embolus after Catheter Removal in Children with Central Venous Catheter Related Venous Thromboembolism: A Report from the CHAT Consortium

Julie Jaffray, MD, Lisa Baumann Kreuziger, MD MS, Brian Branchford, MD, Arash Mahajerin, Choo Phei A Wee, E Vince S Faustino, MD MHS, Zakai A Neil, MD, Stacy E. Croteau, MD, Michael Silvey, DO, John Fargo, DO, James D. Cooper, MD, Nihal Bakeer, MD, Amy Stillings, Emily Krava, Guy Young, MD, Neil A Goldenberg, MD PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-137216

Published: 2020

Journal Articles

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Lynn M. Malec, MD, Gilbert C. White, MD, Stacy E. Croteau, MD, Dunlei Cheng, PhD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 2467.

https://doi.org/10.1182/blood-2018-99-115231

Published: 2018

Journal Articles

Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children's Hospital-Acquired Thrombosis (CHAT) Registry

Brian R. Branchford, MD, Julie Jaffray, MD, Stacy E. Croteau, MD, Michael Silvey, DO, Nihal Bakeer, MBBS, James D. Cooper, MD, John H. Fargo, DO, Lingyun Ji, PhD, Richard Sposto, PhD, Jemily Malvar, Emily Krava, Amy Stillings, Neil A Goldenberg, MD PhD, Guy Young, Arash Mahajerin, MD MS

Blood (2018) 132 (Supplement 1): 142.

https://doi.org/10.1182/blood-2018-99-119968

Published: 2018

Journal Articles

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Madhvi Rajpurkar, MD, Stacy E. Croteau, MD, Lisa N Boggio, MD MS, David L Cooper, MD

Blood (2018) 132 (Supplement 1): 1203.

https://doi.org/10.1182/blood-2018-99-115153

Published: 2018

Journal Articles

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Blood (2018) 132 (Supplement 1): 487.

https://doi.org/10.1182/blood-2018-99-115495

Published: 2018

Journal Articles

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Stacy E. Croteau, MD, Dunlei Cheng, PhD, Alice J. Cohen, MD, Chris E. Holmes, MD PhD, Peter A. Kouides, MD, Leslie J Raffini, MD MSCE, Michael Silvey, DO, Courtney Thornburg, MD, Allison P. Wheeler, MD, Ellis J Neufeld, MD PhD

Blood (2017) 130 (Supplement 1): 23.

https://doi.org/10.1182/blood.V130.Suppl_1.23.23

Published: 2017

Journal Articles

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Rebecca Kruse-Jarres, Michael U. Callaghan, Stacy E. Croteau, MD, Victor Jimenez-Yuste, Liane Khoo, Ri Liesner, Tadashi Matsushita, Michael Recht, Guy Young, Tiffany Chang, Christophe Dhalluin, Yunming Mu, Jin Xu, Jenny Devenport, Richard H. Ko, Paul Solari, Johannes Oldenburg

Blood (2017) 130 (Supplement 1): 89.

https://doi.org/10.1182/blood.V130.Suppl_1.89.89

Published: 2017

Journal Articles

Central Venous Catheters, a Major Culprit for Pediatric Venous Thrombosis: A Report from the Children's Hospital Acquired Thrombosis (CHAT) Project

Julie Jaffray, MD, Arash Mahajerin, MD MS, Stacy E. Croteau, MD, Michael Silvey, DO, Emily Krava, Amy Stillings, Guy Young, Brian R. Branchford, MD

Blood (2017) 130 (Supplement 1): 3706.

https://doi.org/10.1182/blood.V130.Suppl_1.3706.3706

Published: 2017

Journal Articles

Hemophilia Joint Health Score Poorly Predicts the Need for Musculoskeletal Referrals in Routine Clinical Practice

Kim Cattivelli, MD, Hasan Al-Sayegh, MBChB, MPH, Amanda Boyer, PT, DPT, PCS, Elizabeth Mirek, PT, DPT, PCS, Clement Ma, PhD, Ellis J Neufeld, MD PhD, Stacy E. Croteau, MD MMS

Blood (2016) 128 (22): 3784.

https://doi.org/10.1182/blood.V128.22.3784.3784

Published: 2016

NARROW

Assessing Patient and Provider Perspectives, Clinical Practice, Behaviors, and Knowledge on Hemophilia A Care

First-in-Human Phase 1/2 Clinical Trial of SIG-001, an Innovative Shielded Cell Therapy Platform, for Hemophilia Α

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Incidence of Pulmonary Embolus after Catheter Removal in Children with Central Venous Catheter Related Venous Thromboembolism: A Report from the CHAT Consortium

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children's Hospital-Acquired Thrombosis (CHAT) Registry

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Central Venous Catheters, a Major Culprit for Pediatric Venous Thrombosis: A Report from the Children's Hospital Acquired Thrombosis (CHAT) Project

Hemophilia Joint Health Score Poorly Predicts the Need for Musculoskeletal Referrals in Routine Clinical Practice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only